PAX5 and neoplasm: Similarly, heterozygous loss of Pax5 is not sufficient for tumor formation, as it additionally requires constitutive activation (ca) of STAT5 for leukemia development in transgenic caStat5b Pax5+/− mice (Heltemes‐Harris et al, 2011).